SUMMARY Maternal serum a1-antitrypsin concentrations were measured serially in pregnant women who were normotensive and those with mild, moderate, and severe hypertension of pregnancy from 27 weeks' gestation to term. a1-antitrypsin concentrations increased with advancing gestation in all four groups. In addition, the hypertensive pregnancies showed higher than normal concentrations at each stage of pregnancy, with values in the severe hypertension group being higher than values in the other two hypertensive groups. At 35-36 weeks' gestation to term the increase in a,-antitrypsin in the severe hypertension group was significant (p < 0-05) when compared with the normotensive group. Although plasma oestriol and progesterone concentrations increased with advancing gestation in all groups, there was no direct relation between their concentrations and the increase in a,-antitrypsin concentration in the hypertensive groups.
Human plasma proteinase inhibitors are a group of proteins with the specific property of neutralising proteinase activity in either plasma or tissue. Of the eight known plasma proteinase inhibitors, a, antitrypsin and a2-macroglobulin appear to be the most important.' Both these proteinase inhibitors neutralise the elastolytic leucocyte proteinases. Of the two a,-antitrypsin is responsible for at least 70% of the total inhibitory activity in nonpregnancy2 and up to 96% during pregnancy.3 a,-antitrypsin is an acute phase protein; its function is to protect tissues from released proteolytic enzymes, in particular the elastic tissues of the lung. Since the work of Ganrot and Bjerre, 4 
